Baldwin Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Sell
64,436
-372
-0.6% -$86.7K 1.07% 24
2026
Q1
$15.8M Sell
64,808
-2,388
-4% -$556K 1.15% 23
2025
Q4
$13.9M Sell
67,196
-662
-1% -$131K 0.89% 32
2025
Q3
$12.6M Sell
67,858
-3,828
-5% -$656K 0.82% 35
2025
Q2
$10.9M Sell
71,686
-2,232
-3% -$343K 0.74% 41
2025
Q1
$12.3M Sell
73,918
-10,419
-12% -$1.63M 0.86% 36
2024
Q4
$12.2M Sell
84,337
-5,823
-6% -$902K 0.84% 37
2024
Q3
$14.6M Sell
90,160
-3,322
-4% -$529K 1% 29
2024
Q2
$13.7M Sell
93,482
-1,950
-2% -$290K 1.06% 28
2024
Q1
$15.1M Sell
95,432
-3,070
-3% -$489K 1.14% 27
2023
Q4
$15.4M Sell
98,502
-1,463
-1% -$224K 1.21% 25
2023
Q3
$15.6M Sell
99,965
-1,880
-2% -$310K 1.34% 23
2023
Q2
$16.9M Sell
101,845
-1,525
-1% -$246K 1.38% 22
2023
Q1
$16M Buy
103,370
+12
+0% +$1.94K 1.4% 21
2022
Q4
$18.3M Buy
103,358
+69,889
+209% +$12.1M 1.66% 14
2022
Q3
$5.47M Sell
33,469
-2,341
-7% -$396K 0.76% 40
2022
Q2
$6.36M Sell
35,810
-226
-0.6% -$40.3K 0.82% 35
2022
Q1
$6.39M Buy
36,036
+1,045
+3% +$178K 0.68% 42
2021
Q4
$5.99M Buy
34,991
+270
+0.8% +$44.2K 0.6% 45
2021
Q3
$5.61M Sell
34,721
-127
-0.4% -$21.7K 0.62% 43
2021
Q2
$5.74M Buy
34,848
+40
+0.1% +$6.62K 0.63% 45
2021
Q1
$5.72M Buy
34,808
+141
+0.4% +$22.8K 0.68% 44
2020
Q4
$5.46M Sell
34,667
-15
-0% -$2.21K 0.69% 44
2020
Q3
$5.16M Sell
34,682
-200
-0.6% -$29.6K 0.71% 43
2020
Q2
$4.91M Sell
34,882
-484
-1% -$70.5K 0.72% 44
2020
Q1
$4.64M Sell
35,366
-1,703
-5% -$242K 0.81% 40
2019
Q4
$5.41M Sell
37,069
-25
-0.1% -$3.39K 0.76% 42
2019
Q3
$4.8M Sell
37,094
-600
-2% -$79K 0.72% 46
2019
Q2
$5.25M Sell
37,694
-2,035
-5% -$282K 0.77% 42
2019
Q1
$5.55M Buy
39,729
+873
+2% +$117K 0.83% 42
2018
Q4
$5.01M Sell
38,856
-666
-2% -$92.9K 0.84% 41
2018
Q3
$5.46M Buy
39,522
+1,742
+5% +$231K 0.76% 42
2018
Q2
$4.58M Sell
37,780
-727
-2% -$90.7K 0.71% 47
2018
Q1
$4.93M Sell
38,507
-258
-0.7% -$34.9K 0.8% 43
2017
Q4
$5.42M Sell
38,765
-21
-0.1% -$2.92K 0.84% 41
2017
Q3
$5.04M Sell
38,786
-663
-2% -$87.9K 0.81% 43
2017
Q2
$5.22M Sell
39,449
-1,875
-5% -$239K 0.84% 40
2017
Q1
$5.15M Sell
41,324
-18,134
-30% -$2.17M 0.85% 39
2016
Q4
$6.85M Buy
59,458
+3,027
+5% +$350K 1.24% 31
2016
Q3
$6.67M Sell
56,431
-2,420
-4% -$294K 1.21% 29
2016
Q2
$7.14M Sell
58,851
-4,061
-6% -$461K 1.47% 27
2016
Q1
$6.81M Buy
62,912
+4,401
+8% +$456K 1.22% 27
2015
Q4
$6.01M Sell
58,511
-7,446
-11% -$749K 0.98% 32
2015
Q3
$6.16M Sell
65,957
-2,935
-4% -$284K 1.04% 33
2015
Q2
$6.71M Sell
68,892
-418
-0.6% -$41.9K 1% 35
2015
Q1
$6.97M Sell
69,310
-14,380
-17% -$1.46M 1.03% 32
2014
Q4
$8.75M Sell
83,690
-12,125
-13% -$1.28M 1.27% 28
2014
Q3
$10.2M Buy
95,815
+20,530
+27% +$2.13M 1.45% 21
2014
Q2
$7.88M Sell
75,285
-805
-1% -$81.4K 1.17% 28
2014
Q1
$7.47M Sell
76,090
-5,233
-6% -$485K 1.2% 30
2013
Q4
$7.45M Buy
81,323
+3,128
+4% +$288K 1.2% 31
2013
Q3
$6.78M Buy
78,195
+15,750
+25% +$1.41M 1.24% 31
2013
Q2
$5.36M Buy
+62,445
New +$5.3M 1.06% 31

Other funds holding JNJ

Baldwin Wealth Partners's JNJ Position: Q2 2026 in Review

Baldwin Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 0.57% in Q2 2026, selling an estimated $86.7K and leaving 64,436 shares worth $16.4M. The position accounts for 1.07% of the portfolio, ranked #24.

Baldwin Wealth Partners first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.3M in Q4 2022. 2,252 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Baldwin Wealth Partners held 64,436 shares of Johnson & Johnson worth $16.4M as of Q2 2026.
  • Baldwin Wealth Partners sold 372 Johnson & Johnson shares in Q2 2026, an estimated $86.7K.
  • Johnson & Johnson made up 1.07% of Baldwin Wealth Partners's portfolio in Q2 2026, its #24 holding.
  • Baldwin Wealth Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Baldwin Wealth Partners's Johnson & Johnson position peaked at $18.3M in Q4 2022.
  • 2,252 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.